Dear members of the American Society for Transplantation and Cellular Therapy,
The field of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly evolving with great potential to improve patient care. In order to keep pace with these advances, ASTCT is committed to expanding its focus in clinical and translational science and education.
In the past year, we have bolstered our efforts in these areas by creating a new taskforce devoted to basic science and translational research, that will identify new opportunities and set the scientific agenda for the Society. We are also partnering with leading institutions to offer educational programs and resources.
We are also pleased to announce that the ASTCT Clinical Research Training Course (CRTC) will be held in July 12 – 16. Each year, the CRTC provides an opportunity for 12 scholars to work 1:1 with the course faculty and statisticians through formal presentations and extensive follow-up dialogue and small-group discussion.
We’ve continued to build upon our focus on science, including expanded content for Tandem, hosting the 2nd Joint ASTCT-EBMT Basic and Translational Scientific Meeting and a new training course for translational research in 2024. We believe that these efforts will help us to better serve our members and the patients they care for and thank you for your support as we work to build a brighter future for HCT and CT. Please feel free to reach out with comments and/or suggestions.
Miguel Perales, MD
Disclosure: The first draft of this message was written with ChatGPT.
Tags: astct, transplantation, Cell, President, clinical, president message